Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5924240 | 1.00 | ABCB1 (0.32) | ABCB1CTSD | |
| SCHEMBL5207843 | 1.00 | ABCB1 (0.32) | ABCB1CTSD | |
| SCHEMBL5924497 | 0.82 | — | — | |
| SCHEMBL5924319 | 0.79 | KDM4E (0.41) | CTSD | |
| SCHEMBL16080204 | 0.77 | ABCB1 (0.30) | ABCB1 | |
| SCHEMBL25484894 | 0.77 | CTSD (0.32) | ABCB1CTSD | |
| SCHEMBL24443112 | 0.77 | — | — | |
| SCHEMBL24743669 | 0.74 | PLA2G10 (0.31) | — | |
| SCHEMBL15359750 | 0.69 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL10326860 | 0.69 | AHR (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088071-A1 | SUBSTITUTED FUSED HETEROARYL LACTAM COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20070088163-A1 | Modulators of calcitonin and amylin activity | KEMIA, INC. | 2007-04-19 | — | — | US | disclosed |
| US-20070088163-A1 | Modulators of calcitonin and amylin activity | KEMIA, INC. | 2007-04-19 | — | — | US | disclosed |
| US-20070088163-A1 | Modulators of calcitonin and amylin activity | KEMIA, INC. | 2007-04-19 | — | — | US | disclosed |
| WO-2005025504-A2 | MODULATORS OF CALCITONIN AND AMYLIN ACTIVITY | KEMIA, INC. (US) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088163-A1 | Modulators of calcitonin and amylin activity | CALCRL, CALCR, CALCA | ABCB1 3860/4885CTSD 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.